Buteyko Breathing vs Incentive Spirometry for Smog-Induced Pneumonia
Official title: Effects of Buteyko Breathing Versus Incentive Spirometry on Oxygen Saturation, Dyspnoea, Exercise Tolerance, and Sputum Clearance in Patients With Smog Induced Pneumonia
Run by Lahore University of Biological and Applied Sciences · NCT07759583 · Data updated 2026-11-12
We’re testing whether the Buteyko Breathing Technique can improve oxygen levels and breathe easier for adults with smog-related pneumonia compared to incentive spirometry.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 40 Years |
| Sex | All |
| Enrollment | 62 (estimated) |
| Sponsor | Lahore University of Biological and Applied Sciences Academic / other |
| Locations | 1 site (Lahore, Punjab Province) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | August 15, 2026 |
| Study ends | October 15, 2026 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT07759583 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 25–40 with clinically diagnosed pneumonia and recent high air pollution exposure, capable of performing breathing exercises.
✕Probably not a fit
Patients with severe respiratory failure, hemodynamic instability, or conditions preventing participation from performing breathing exercises may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-blind, parallel-group randomized trial enrolling about 62 adults with smog-induced pneumonia. Participants are randomly assigned to either Buteyko Breathing Technique plus standard care or Incentive Spirometry plus standard care, with sessions twice daily for 20–30 minutes over a week or until discharge. Primary outcomes include oxygen saturation, dyspnea, exercise tolerance, sputum clearance, and respiratory symptoms, measured at baseline, Day 3, Week 2, and Week 4. The study is conducted at a hospital in Lahore, focusing on how breathing retraining versus airway clearance strategies affect recovery from pollution-associated pneumonia.
Why it matters
Potential benefit: If successful, patients may experience quicker relief from breathlessness and better oxygenation during recovery from smog-induced pneumonia.
How similar studies have gone: Breathing techniques and pulmonary rehabilitation have shown benefits in respiratory infections, but direct comparison with incentive spirometry in smog-related pneumonia is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Male and female participants Age between 25-40 years Clinically diagnosed pneumonia Recent exposure to high air pollution levels (AQI threshold exceeded within the past 7 days) Resting oxygen saturation between 86-95% Ability to understand and perform breathing exercises - Exclusion Criteria: Requirement for mechanical ventilation or ICU admission Hemodynamic instability Severe chronic respiratory disease such as COPD with hypercapnia Pneumothorax or massive hemoptysis Recent thoracic surgery or trauma Cognitive impairment affecting cooperation Pregnancy \-
Where it's running
-
Combined Military Hospital (CMH)
Lahore, Punjab Province, Pakistan Recruiting
Study contacts
- Study coordinator: Faizan Ahmad
- Email: faizanxahmad21@gmail.com
- Phone: 03054741978
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
Optimising Antibiotic Use for Paediatric LRTIs in Africa
This study tests whether using point-of-care CRP tests together with the PREPARE score can safely reduce antibiotic use in infants aged 2–24 months with lower respiratory infections in a Johannesburg hospital.
-
FUNGAL-P: A score to spot fungal pneumonia early in adults with pneumonia
Aimed at adults with pneumonia, this study tests a new score to help identify fungal pneumonia sooner so doctors can test appropriately and start antifungal treatment when needed.
-
AgenT-797 plus standard care in severe pneumonia with acute hypoxemic respiratory failure
We are testing whether a single IV dose of agenT-797 added to standard care can reduce short-term death in adults with severe pneumonia and moderate to severe AHRF.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.